COMP <GO>
COO vs UNH // 10Y YIELD & FRED MACRO BETA
The Cooper Companies Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: COO 6
— UNH 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: COO
LAST: $59.55 (-1.31%) • MKT CAP: $11.47B
macro-sensitivity
1.01
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (COO VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | COO | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 65.50% | 88.57% | -23.07 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.30% | 11.47% | -6.17 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.3x | 16.4x | -3.15 | COO | /valuation <GO> |
| Free Cash Flow Yield | 3.78% | 6.48% | -2.70 | UNH | /fcf-yield <GO> |
| Operating Margin | 16.70% | 4.82% | +11.88 | COO | /operating-margins <GO> |
| Net Profit Margin | 9.20% | 3.14% | +6.06 | COO | /net-margins <GO> |
| Revenue Growth (YoY) | 5.10% | 6.46% | -1.36 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.13 | 3.12 | +0.01 | COO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | COO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.74% | +0.16 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 56.0 | -3.53 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.01 | 0.33 | +0.68 | COO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.5x | 17.1x | +11.41 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.47B | $364.66B | -$353.19B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | COO REV | UNH REV | COO GROSS % | UNH GROSS % | COO FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.09B | $447.57B | 65.5% | 88.7% | $433.7M | $16.07B |
| FY 2024 | $3.90B | $400.28B | 66.6% | 88.3% | $288.1M | $20.70B |
| FY 2023 | $3.59B | $371.62B | 44.0% | 89.6% | $445.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
COO // BETA 1.01
UNH // BETA 0.33